Literature DB >> 8795672

Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study.

C P Engström1, L O Persson, S Larsson, A Rydén, M Sullivan.   

Abstract

BACKGROUND: Self-assessment questionnaires which measure the functional and affective consequences of chronic obstructive pulmonary disease (COPD) give valuable information about the effects of the disease and may serve as important tools with which to evaluate treatment.
METHODS: A cross sectional comparative study was performed between patients with COPD (n = 68), stratified according to pulmonary function, and a healthy control group (n = 89). A battery of well established clinical and quality of life measures (the Sickness Impact Profile (SIP), Mood Adjective Check List (MACL), and Hospital Anxiety and Depression scale (HAD)) was used to examine in which functional and affective aspects the patient group differed from the control group and how these measures related to pulmonary function and smoking habits.
RESULTS: Compared with the controls, COPD affected functional status in most areas, not just those requiring physical activity. Forty six patients with forced expiratory volume in one second (FEV1) below 50% predicted showed particularly high levels of dysfunction in ambulation, eating, home management, and recreation/ pastimes (SIP). Despite this, their level of psychosocial functioning and mood status was little different from that of the healthy controls. Among the patients, a subgroup reported substantial psychological distress, but mood status was only weakly, or not at all, related to pulmonary function. Smoking habits did not affect functional status or well being.
CONCLUSIONS: Quality of life is not significantly affected in patients with mild to moderate loss of pulmonary function, possibly due to coping and/or pulmonary reserve capacity. This suggests that generic self-assessment questionnaires are of limited value for detecting the early consequences of COPD. However, in later stages of the disease they are sensitive enough to discriminate between patients with different levels of pulmonary dysfunction. The low correlations between the indices of pulmonary function and the indices of affective status suggest that well being depends, to a large extent, on factors outside the clinical domain.

Entities:  

Mesh:

Year:  1996        PMID: 8795672      PMCID: PMC472558          DOI: 10.1136/thx.51.8.825

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  26 in total

1.  Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial.

Authors:  D O Wilson; R M Rogers; E C Wright; N R Anthonisen
Journal:  Am Rev Respir Dis       Date:  1989-06

Review 2.  Standards for validating health measures: definition and content.

Authors:  J E Ware
Journal:  J Chronic Dis       Date:  1987

3.  The measurement of mood.

Authors:  L Sjöberg; E Svensson; L O Persson
Journal:  Scand J Psychol       Date:  1979

4.  Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease.

Authors:  G P Prigatano; E C Wright; D Levin
Journal:  Arch Intern Med       Date:  1984-08

5.  Life quality of patients with chronic obstructive pulmonary disease.

Authors:  A J McSweeny; I Grant; R K Heaton; K M Adams; R M Timms
Journal:  Arch Intern Med       Date:  1982-03

6.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

7.  A validation study of three anxiety and depression self-assessment scales.

Authors:  P R Aylard; J H Gooding; P J McKenna; R P Snaith
Journal:  J Psychosom Res       Date:  1987       Impact factor: 3.006

8.  Measuring health in rheumatic disorders by means of a Swedish version of the sickness impact profile. Results from a population study.

Authors:  M Sullivan; M Ahlmén; B Archenholtz; G Svensson
Journal:  Scand J Rheumatol       Date:  1986       Impact factor: 3.641

9.  Quality-of-life in a long-term multicentre trial in chronic nonspecific lung disease: assessment at baseline. The Dutch CNSLD Study Group.

Authors:  A A Kaptein; P L Brand; F W Dekker; H A Kerstjens; D S Postma; H J Sluiter
Journal:  Eur Respir J       Date:  1993-11       Impact factor: 16.671

10.  Impairment, disability and handicap in chronic respiratory illness.

Authors:  S J Williams; M R Bury
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

View more
  31 in total

1.  Outcomes in cardiopulmonary physical therapy: sickness impact profile.

Authors:  Sheronda Bowers; Katie Cannizzaro; Jessica Gregus; Quanteria Scott; Jane Eason
Journal:  Cardiopulm Phys Ther J       Date:  2009-03

Review 2.  Health status measurement in chronic obstructive pulmonary disease.

Authors:  P W Jones
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

Review 3.  End-of-life considerations in older patients who have lung disease.

Authors:  Renee D Stapleton; J Randall Curtis
Journal:  Clin Chest Med       Date:  2007-12       Impact factor: 2.878

4.  Are anxiety and depression addressed in primary care patients with chronic obstructive pulmonary disease? A chart review.

Authors:  Kent Roundy; Jeffrey A Cully; Melinda A Stanley; Connie Veazey; Julianne Souchek; Nelda P Wray; Mark E Kunik
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

5.  Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study.

Authors:  Nicholas D Giardino; Jeffrey L Curtis; Adin-Cristian Andrei; Vincent S Fan; Joshua O Benditt; Mark Lyubkin; Keith Naunheim; Gerard Criner; Barry Make; Robert A Wise; Susan K Murray; Alfred P Fishman; Frank C Sciurba; Israel Liberzon; Fernando J Martinez
Journal:  Respir Res       Date:  2010-03-09

6.  Activity of aclidinium bromide, a new long-acting muscarinic antagonist: a phase I study.

Authors:  Vanessa J Schelfhout; Pau Ferrer; Josep Maria Jansat; Francesc Peris; Esther Garcia Gil; Romain A Pauwels; Guy F Joos
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

7.  Comparative Study of Cytokine Levels in Different Respiratory Samples in Mild-to-Moderate AECOPD Patients.

Authors:  Wendong Hao; Manxiang Li; Yunqing Zhang; Cailian Zhang; Ping Wang
Journal:  Lung       Date:  2019-08-26       Impact factor: 2.584

8.  Depression and health-related quality of life in chronic obstructive pulmonary disease.

Authors:  Theodore A Omachi; Patricia P Katz; Edward H Yelin; Steven E Gregorich; Carlos Iribarren; Paul D Blanc; Mark D Eisner
Journal:  Am J Med       Date:  2009-08       Impact factor: 4.965

Review 9.  Depression in COPD--management and quality of life considerations.

Authors:  Kurt B Stage; Thomas Middelboe; Tore B Stage; Claus H Sørensen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: a number needed to treat study.

Authors:  Gian Galeazzo Riario-Sforza; Cristoforo Incorvaia; Fulvia Paterniti; Laura Pessina; Roberta Caligiuri; Chiara Pravettoni; Fabiano Di Marco; Stefano Centanni
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.